Role of Adaptive Radiotherapy During Concomitant Chemoradiotherapy for Lung Cancer: Analysis of Data From a Prospective Clinical Trial

International Journal of Radiation Oncology Biology Physics

Volumn 75, Issue 4, 2009, Pages 1092-1097

  Spoelstra, Femke O B ^a   Pantarotto, Jason R ^a   van Sörnsen de Koste, John R ^a   Slotman, Ben J ^a   Senan, Suresh ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Adaptive radiotherapy; Four dimensional computed tomography; Lung cancer; Respiratory gating; Time trends

Indexed keywords

ADAPTIVE RADIOTHERAPY; FOUR-DIMENSIONAL COMPUTED TOMOGRAPHY; LUNG CANCER; RESPIRATORY GATINGS; TIME TRENDS;

BIOLOGICAL ORGANS; COMPUTERIZED TOMOGRAPHY; DOSIMETERS; DOSIMETRY; PATIENT MONITORING; RESPIRATORY MECHANICS; TOMOGRAPHY; TOXICITY;

RADIOTHERAPY;

ANTINEOPLASTIC AGENT;

ADAPTIVE RADIOTHERAPY; ADULT; AGED; ARTICLE; BREATHING; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER SIZE; CANCER STAGING; CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DATA ANALYSIS; DISEASE COURSE; DOSIMETRY; FEMALE; FORCED EXPIRATORY VOLUME; FOUR DIMENSIONAL COMPUTER ASSISTED TOMOGRAPHY; HUMAN; IMAGE ANALYSIS; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MALE; ORGAN; PLANNING TARGET VOLUME; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION DOSE FRACTIONATION; TIME; TREATMENT PLANNING; TUMOR VOLUME; ALGORITHM; COMPUTER ASSISTED RADIOTHERAPY; LUNG TUMOR; METHODOLOGY; MIDDLE AGED; MOVEMENT (PHYSIOLOGY); MULTIMODALITY CANCER THERAPY; PATHOLOGY; RADIATION DOSE; RADIOGRAPHY;

AGED; ALGORITHMS; CARCINOMA, NON-SMALL-CELL LUNG; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MOVEMENT; PROSPECTIVE STUDIES; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; RESPIRATION; TOMOGRAPHY, X-RAY COMPUTED; TUMOR BURDEN;

EID: 65749087129     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.12.027     Document Type: Article

References (20)

1. Robinson L.A., Ruckdeschel J.C., Wagner Jr. H., et al. Treatment of non-small cell lung cancer-stage IIIA: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 132 (2007) 243S-265S
2. Albain K.S., Crowley J.J., Turrisi III A.T., et al. Concurrent cisplatin, etoposide, and chest radiotherapy in pathologic stage IIIB non-small-cell lung cancer: A Southwest Oncology Group phase II study, SWOG 9019. J Clin Oncol 20 (2002) 3454-3460
3. Yuan S., Sun X., Li M., et al. A randomized study of involved-field irradiation versus elective nodal irradiation in combination with concurrent chemotherapy for inoperable stage III nonsmall cell lung cancer. Am J Clin Oncol 30 (2007) 239-244
4. Underberg R.W., Lagerwaard F.J., Cuijpers J.P., et al. Four-dimensional CT scans for treatment planning in stereotactic radiotherapy for stage I lung cancer. Int J Radiat Oncol Biol Phys 60 (2004) 1283-1290
5. Spoelstra F.O., van Sornsen de Koste J.R., Cuijpers J.P., et al. Analysis of reproducibility of respiration-triggered gated radiotherapy for lung tumors. Radiother Oncol 87 (2008) 59-64
6. Keall P.J., Kini V.R., Vedam S.S., et al. Potential radiotherapy improvements with respiratory gating. Australas Phys Eng Sci Med 25 (2002) 1-6
7. Underberg R.W., van Sornsen de Koste J.R., Lagerwaard F.J., et al. A dosimetric analysis of respiration-gated radiotherapy in patients with stage III lung cancer. Radiat Oncol 1 (2006) 8
8. Hansen E.K., Bucci M.K., Quivey J.M., et al. Repeat CT imaging and replanning during the course of IMRT for head-and-neck cancer. Int J Radiat Oncol Biol Phys 64 (2006) 355-362
9. Haasbeek C.J., Lagerwaard F.J., Cuijpers J.P., et al. Is adaptive treatment planning required for stereotactic radiotherapy of stage I non-small-cell lung cancer?. Int J Radiat Oncol Biol Phys 67 (2007) 1370-1374
10. International Commission on Radiation Units and Measurements. ICRU report 62: Prescribing, recording, and reporting photon beam therapy (supplement to ICRU report 50) (1999), International Commission on Radiation Units and Measurements, Bethesda
11. Turrisi III A.T., Kim K., Blum R., et al. Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide. N Engl J Med 340 (1999) 265-271
12. Chang J., Mageras G.S., Yorke E., et al. Observation of interfractional variations in lung tumor position using respiratory gated and ungated megavoltage cone-beam computed tomography. Int J Radiat Oncol Biol Phys 67 (2007) 1548-1558
13. Siker M.L., Tome W.A., and Mehta M.P. Tumor volume changes on serial imaging with megavoltage CT for non-small-cell lung cancer during intensity-modulated radiotherapy: How reliable, consistent, and meaningful is the effect?. Int J Radiat Oncol Biol Phys 66 (2006) 135-141
14. Bosmans G., van B.A., Dekker A., et al. Intra-patient variability of tumor volume and tumor motion during conventionally fractionated radiotherapy for locally advanced non-small-cell lung cancer: A prospective clinical study. Int J Radiat Oncol Biol Phys 66 (2006) 748-753
15. Kupelian P.A., Ramsey C., Meeks S.L., et al. Serial megavoltage CT imaging during external beam radiotherapy for non-small-cell lung cancer: Observations on tumor regression during treatment. Int J Radiat Oncol Biol Phys 63 (2005) 1024-1028
16. Erridge S.C., Seppenwoolde Y., Muller S.H., et al. Portal imaging to assess set-up errors, tumor motion and tumor shrinkage during conformal radiotherapy of non-small cell lung cancer. Radiother Oncol 66 (2003) 75-85
17. Michalski D., Sontag M., Li F., et al. Four-dimensional computed tomography-based interfractional reproducibility study of lung tumor intrafractional motion. Int J Radiat Oncol Biol Phys 71 (2008) 714-724
18. Woodford C., Yartsev S., Dar A.R., et al. Adaptive radiotherapy planning on decreasing gross tumor volumes as seen on megavoltage computed tomography images. Int J Radiat Oncol Biol Phys 69 (2007) 1316-1322
19. Rusch V.W., Giroux D.J., Kraut M.J., et al. Induction chemoradiation and surgical resection for superior sulcus non-small-cell lung carcinomas: Long-term results of Southwest Oncology Group trial 9416 (Intergroup trial 0160). J Clin Oncol 25 (2007) 313-318
20. van Baardwijk A., Bosmans G., van Suylen R.J., et al. Correlation of intra-tumour heterogeneity on 18F-FDG PET with pathologic features in non-small cell lung cancer: A feasibility study. Radiother Oncol 87 (2008) 55-58